The conventional view is that alcohol metabolism is carried out by ADH1 (Class I) in the liver. However, it has been suggested that another pathway plays an important role in alcohol metabolism, especially when the level of blood ethanol is high or when drinking is chronic. Over the past three decades, vigorous attempts to identify the enzyme responsible for the non-ADH1 pathway have focused on the microsomal ethanol oxidizing system (MEOS) and catalase, but have failed to clarify their roles in systemic alcohol metabolism. Recently, using ADH3-null mutant mice, we demonstrated that ADH3 (Class III), which has a high Km and is a ubiquitous enzyme of ancient origin, contributes to systemic alcohol metabolism in a dose-dependent manner, thereby diminishing acute alcohol intoxication. Although the activity of ADH3 toward ethanol is usually low in vitro due to its very high Km, the catalytic efficiency ( kcat/Km) is markedly enhanced when the solution hydrophobicity of the reaction medium increases. Activation of ADH3 by increasing hydrophobicity should also occur in liver cells; a cytoplasmic solution of mouse liver cells was shown to be much more hydrophobic than a buffer solution when using Nile red as a hydrophobicity probe. When various doses of ethanol are administered to mice, liver ADH3 activity is dynamically regulated through induction or kinetic activation, while ADH1 activity is markedly lower at high doses (3–5 g/kg). These data suggest that ADH3 plays a dynamic role in alcohol metabolism, either collaborating with ADH1 or compensating for the reduced role of ADH1. A complex two-ADH model that ascribes total liver ADH activity to both ADH1 and ADH3 explains the dose-dependent changes in the pharmacokinetic parameters (b, CL T, AUC) of blood ethanol very well, suggesting that alcohol metabolism in mice is primarily governed by these two ADHs. In patients with alcoholic liver disease, liver ADH3 activity increases, while ADH1 activity decreases, as alcohol intake increases. Furthermore, ADH3 is induced in damaged cells that have greater hydrophobicity, whereas ADH1 activity is lower when there is severe liver disease. These data suggest that chronic binge drinking and the resulting liver disease shifts the key enzyme in alcohol metabolism from low- Km ADH1 to high- Km ADH3, thereby reducing the rate of alcohol metabolism. The interdependent increase in the ADH3/ADH1 activity ratio and AUC may be a factor in the development of alcoholic liver disease. However, the adaptive increase in ADH3 sustains alcohol metabolism, even in patients with
References
[1]
Crow, KE; Hardman, MJ. Regulation of rates of ethanol metabolism. In Regulation, Enzymology, and Metabolites of Ethanol, Human Metabolism of Alcohol; Crow, KE, Batt, RD, Eds.; CRC Press Inc: Boca Raton, FL, USA, 1989; Volume 2, pp. 3–16.
[2]
Lieber, CS; DeCarli, LM. The role of the hepatic microsomal ethanol oxidizing system (MEOS) for ethanol metabolism in vivo. J. Pharmacol. Exp. Ther？1972, 181, 279–287.
[3]
Matsuzaki, S; Lieber, CS. ADH-independent ethanol oxidation in the liver and its increase by chronic ethanol consumption. Gastroenterology？1975, 69, 845.
[4]
Feinman, L; Baraona, E; Matsuzaki, S; Korsten, M; Lieber, CS. Concentration dependence of ethanol metabolism in vivo in rats and man. Alc. Clin. Exp. Res？1978, 2, 381–385.
[5]
Pikkarainen, P; Lieber, CS. Concentration dependency of ethanol elimination rates in baboons: Effect of chronic alcohol consumption. Alc. Cli. Exp. Res？1980, 4, 40–43.
[6]
Matsuzaki, S; Gordon, E; Lieber, CS. Increased alcohol dehydrogenase independent ethanol oxidation at high ethanol concentration in isolated rat hepatocytes: the effects of chronic ethanol feeding. J. Pharm. & Exp. Ther？1981, 217, 133–137.
[7]
Lieber, CS; DeCarli, LM. Hepatic microsomal ethanol-oxidizing system: In vitro characteristics and adaptive properties in vivo. J. Biol. Chem？1970, 245, 2505–2512.
[8]
Shigeta, Y; Nomura, F; Iida, S; Leo, MA; Felder, MR; Lieber, CS. Ethanol metabolism in vivo by the microsomal ethanol-oxidizing system in deermice lacking alcohol dehydrogenase (ADH). Biochem. Pharmacol？1984, 33, 807–814.
[9]
Teschke, R; Gellert, J. Hepatic microsomal ethanol-oxidizing system (MEOS): Metabolic aspects and clinical implications. Alc. Clin. Exp. Res？1986, 10, 20S–32S.
[10]
Thurman, RG; Ley, HG; Scholz, R. Hepatic microsomal ethanol oxidation-Hydrogen peroxide formation and the role of catalase. Eur. J. Biochem？1972, 25, 420–430.
[11]
Handler, JA; Bradford, BU; Glassman, E; Ladine, JK; Thurman, RG. Catalase-dependent ethanol metabolism in vivo in deermice lacking alcohol dehydrogenase. Biochem. Pharmacol？1986, 35, 4487–4492.
[12]
Bradford, BU; Seed, CB; Handler, JA; Forman, DT; Thurman, RG. Evidence that catalase is a major pathway of ethanol oxidation in vivo: Dose-response studies in deermice using methanol as selective substrate. Arch. Biochem. Biophys？1993, 303, 172–176.
[13]
Haseba, T; Hirakawa, K; Nihira, M; Hayashida, M; Kurosu, M; Tomita, Y; Ide, T; Watanabe, T. Partial purification and characterization of alcohol dehydrogenases from mouse liver. J Stud Alcohol？1979, 14, 324. (in Japanese).
[14]
Haseba, T; Hirakawa, K; Tomita, Y; Watanabe, T. Characterization of high Km alcohol dehydrogenase from mouse liver. In Electrophoresis ‘83; Hirai, H, Ed.; Walter de Gruyter & Co: Berlin, Germany, and New York, NY, USA, 1984; pp. 393–400.
[15]
Vallee, BL; Bazzone, TJ. Isozymes of human liver alcohol dehydrogenase. In Isozymes, Current Topics in Biological and Medical Research; Scandolios, JG, Rattazzi, MC, Whitt, GS, Eds.; Alan R Liss: New York, NY, USA, 1983; Volume 8, pp. 219–244.
[16]
Haseba, T. Acidic pI-Alcohol dehydrogenase of mouse liver. Jpn. J. Alcohol Drug Depend？1985, 20, 333–349.
[17]
Haseba, T; Kurosu, M; Tomita, Y; Hirakawa, K; Kamii, H; Nihira, M; Watanabe, T. Characterization of a new type of pyarzole-insensitive alcohol dehydrogenase and the role in alcohol metabolism. In Alcohol Metabolism and Liver; Toyo Shoten: Tokyo, Japan, 1987; Volume 6, pp. 18–28. (in Japanese).
[18]
Kamii, H. Pyrazole sensitive and pyrazole insensitive-alcohol dehydrogenase activities in biopsied livers of patients with alcoholic liver disease. J Nippon Med Sch？1988, 55, 236–246. (in Japanese).
[19]
Haseba, T; Sato, S; Ishizaki, M; Yamamoto, I; Kurosu, M; Watanabe, T. Intralobular and intracellular localization of alcohol dehydrogenase (ADH) isozymes in mouse liver -Basic ADH (Class I) and Acidic ADH (Class III). Biomed. Res？1991, 12, 199–209.
[20]
Yamamoto, I; Haseba, T; Kurosu, M; Watanabe, T. Allosterism of acidic alcohol dehydrogenase (Class III ADH) of mouse liver and its role in alcohol metabolism. J Nippon Med Sch？1992, 59, 38–46. (in Japanese).
[21]
Haseba, T; Yamamoto, I; Ohno, Y; Watanabe, T. Alcohol dehydrogenase (ADH) isozymes in AdhN/AdhN strain of Peromyscus maniculatus (ADH？ deermice) and a possible role of Class III ADH in alcohol metabolism. Biochem. Genet？1995, 33, 349–362.
[22]
Kameyama, K; Haseba, T; Wang, R-J; Machida, T; Machida, M; Onda, M; Mori, O; Asano, G. Expression of alcohol dehydrogenase (ADH) with cytomembrane damage in vascular smooth muscle cell. J. Jap. Coll. Angiol？2000, 40, 259–266.
[23]
Mori, O; Haseba, T; Kameyama, K; Shimizu, H; Kudoh, M; Ohaki, Y; Arai, H; Yamazaki, M; Asano, G. Histological distribution of Class III alcohol dehydrogenase in human brain. Brain Res？2000, 852, 186–190.
[24]
Haseba, T; Tomita, Y; Kurosu, M; Ohno, Y. Dose and time changes in liver alcohol dehydrogenase (ADH) activity during acute alcohol intoxication involve not only class I but also class III ADH and govern elimination rate of blood ethanol. Legal Med？2003, 5, 202–211.
[25]
Haseba, T; Duester, G; Shimizu, A; Yamamoto, I; Kameyama, K; Ohno, Y. In vivo contribution of Class III alcohol dehydrogenase (ADH3) to alcohol metabolism through activation by cytoplasmic solution hydrophobicity. Biochim. Biophys. Acta？2006, 1762, 276–283.
[26]
Deltour, L; Foglio, MH; Duester, G. Metabolic deficiencies in alcohol dehydrogenase Adh1, Adh3 and Adh4 null mutant mice. J. Biol. Chem？1999, 274, 16796–16801.
[27]
Kono, H; Bradford, BU; Yin, M; Sulik, KK; Koop, DR; Peters, JM; Gonzalez, FJ; McDonald, T; Dikalova, A; Kadiiska, MB; Mason, RP; Thurman, RG. CYP2E1 is not involved in early alcohol-induced liver injury. Am. J. Physiol？1999, 277, G1259–1267.
[28]
Weiner, ML; Freeman, C; Trochimowicz, H; DeGerlache, J; Jacobi, S; Malinverno, G; Mayr, W; Regnier, JF. 13-Week drinking water toxicity study of hydrogen peroxide with 6-week recovery period in catalase-deficient mice. Food Chem. Toxicol？2000, 38, 607–615.
[29]
Hammond, KB; Rumack, BH; Rodgerson, DO. Blood ethanol, a report of unusually high levels in a living patient. JAMA？1973, 266, 63–64.
[30]
O’Neill, S; Tipton, KF; Prichard, JS; Quinlan, A. Survival high blood alcohol levels. Association with first-order elimination kinetics. Arch. Intern. Med？1984, 144, 641–642.
[31]
Fujimiya, T; Yamaoka, K; Fukui, Y. Parallel first-order and Michaelis-Menten elimination kinetics of ethanol: Respective role of alcohol dehydrogenase (ADH), non-ADH and first-order pathways. J. Pharmacol. Exp. Ther？1989, 249, 311–317.
[32]
Estonious, M; Svensson, S; Hoog, J-O. Alcohol dehydrogenase in human tissue: localization of transcripts coding for five classes of the enzyme. FEBS Lett？1996, 397, 338–342.
[33]
Pares, X; Vallee, BL. New human liver alcohol dehydrogenase forms with unique kinetic characteristics. Biochem. Biophys. Res. Coummun？1981, 98, 122–130.
[34]
Algar, EM; Seeley, T-E; Holmes, RS. Purification and molecular properties of mouse alcohol dehydrogenase isozymes. Eur. J. Biochem？1983, 137, 139–147.
[35]
Kaiser, R; Holmquist, B; Vallee, BL; Jornvall, H. Characteristics of mammalian Class III alcohol dehydrogenase, an enzyme less variable than traditional liver enzyme of Class I. Biochemistry？1989, 28, 8432–8438.
[36]
Toussaint, J-F; Southern, JF; Fuster, V; Kantor, HL. Water diffusion properties of human atherosclerosis and thrombosis measured by pulse field gradient nuclear magnetic resonance. Arterioscler Thromb. Vasc. Biol？1997, 17, 542–546.
[37]
Baraona, E; Abittan, CS; Dohmen, K; Moretti, M; Pozzato, G; Chayes, ZW; Schaefer, C; Lieber, CS. Gender differences in pharmacokinetics of alcohol. Alc. Clin. Exp. Res？2001, 25, 502–507.
[38]
Haseba, T; Shimizu, A; Kurosawa, N; Kameyama, K; Mashimo, K; Yamamoto, I. Roles of Class III alcohol dehydrogenase (ADH 3), a housekeeping enzyme for cytotoxicity, in alcohol metabolism—in vivo study using knockout mice and in vitro study on regulation of enzyme activity—A Report for a grant-in aid from the Japan Society for the Promotion of Science: Tokyo, Japan. 2002; pp. 114–115.
[39]
Prior, BA; Alexander, MA; Yang, V; Jefferies, TW. The role of alcohol dehydrogenase in the fermentation of xylose by Candida shehatae ATCC 22984. Biotech. Lett？1988, 10, 43–48.
[40]
Andrews, DL; Cobb, BG; Johnson, JR; Drew, MC. Hypoxic and anodic induction of alcohol dehydrogenase in roots and shoots of seedling of zea mays (Adh transcripts and enzyme activity). Plant. Physiol？1993, 101, 407–414.
[41]
Zakhari, S. Overview: How is alcohol metabolized by the body. Alc. Res. Health？2006, 29, 245–254.
[42]
Beisswenger, TB; Holmquist, B; Vallee, BL. χ- ADH is the sole alcohol dehydrogenase isozyme of mammalian brains: Implication and inferences. Proc. Natl. Acad. Sci. USA？1985, 82, 8369–8373.
[43]
Haseba, T; Ohno, Y. Assay methods of alcohol metabolizing enzymes for the research on enzymatic mechanism of alcohol metabolism. Nippon Rinnshou？1997, 55, 665–673. (in Japanese).
[44]
Haseba, T; Kurosu, M; Tomita, Y; Hayashida, M; Hirakawa, K; nihira, M; Watanabe, T; Kadowaki, M. A study of the change of the mouse liver ADH activity involving Class I and Class III ADH after alcohol administration. Jpn. J. Alcohol Drug Depend？1986, 21, 34–35.
[45]
Haseba, T; Kameyama, K; Mashimo, K; Ohno, Y. Dose-dependent change in pharmacokinetics of ethanol in mice due to shifting the dominant metabolizing enzyme from liver Class I ADH to Class III ADH. Alc. Clin. Exp. Res？2000, 24, 199A.
[46]
Braggins, TJ; Crow, KE. The effects of high ethanol doses on rates of ethanol oxidation in rats: A reassessment of factors controlling rates of ethanol oxidation in vivo. Eur. J. Biochem？1981, 119, 633–640.
[47]
Sharkawi, M. In vivo inhibition of liver alcohol dehydrogenase by ethanol administration. Life Sci？1984, 35, 2353–2357.
[48]
Kurosu, M; Haseba, T; Tomita, Y; Kamii, H; Yamamoto, I; Watanabe, T. Effects of chronic ethanol feeding on alcohol dehydrogenase (ADH) isozymes in mouse liver. Alc Alc？1988, A62. The abstracts of 4 congress of ISBRA.
[49]
Haber, PS; Apte, MV; Applegate, TL; Norton, ID; Korsten, MA; Pirola, RC; Wilson, JS. Metabolism of ethanol by rat pancreatic acinar cells. J. Lab. Clin. Med？1998, 132, 294–302.
[50]
Moria, N; Nihira, M; Sato, S; Watanabe, T. Ultrastructural changes of liver, heart, lung and kidney of mice in a large dose of ethanol injection. Jpn. J. Alc. Drug Depend？1992, 27, 189–200.
[51]
Lieber, CS; DeCarli, LM; Rubin, E. Sequential Production of fatty liver, hepatitis, and cirrhosis in sub-human primates fed ethanol with adequate diets. Proc. Natl. Acad. Sci. USA？1975, 72, 437–441.
[52]
Cramer, DD; Kerckaert, I; Roels, F. Hepatocelluar peroxisomes in human alcoholic and drug-induced hepatitis: A quantitative study. Hepatology？1991, 14, 811–817.
[53]
Estonius, M; Danielsson, O; Karlsson, C; Persson, H; Jornvall, H; Hoog, J-O. Distribution of alcohol and sorbitol dehydrogenase: Assessment of mRNAs in rat tissues. Eur. J. Biochem？1993, 215, 497–503.
[54]
Svensson, S; Stromberg, P; Hoog, J-O. A novel subtype of Class II alcohol dehydrogenase in rodents. J. Biol. Chem？1999, 274, 29712–29719.
[55]
Lee, S-L; Chau, G-Y; Yao, CT; Wu, C-W; Yin, S-J. Functional assessment of human alcohol dehydrogenase family in ethanol metabolism: Significance of first-pass metabolism. Alc. Clin. Exp. Res？2006, 30, 1132–1142.
[56]
Kimura, Y; Nishimura, FT; Abe, S; Fukunaga, T; Tanii, H; Saijoh, K. Polymorphisms in the promoter region of the human class II alcohol dehydrogenase (ADH4) gene affect both transcriptional activity and ethanol metabolism in Japanese subjects. J. Toxicol. Sci？2009, 34, 89–97.
[57]
Holmes, RS; Meyer, J; VandeBerg, JL. Baboon alcohol dehydrogenase isozymes: Purification and properties of liver class I ADH. Moderate alcohol consumption reduces liver class I and class II ADH activities. In Isozymes: Structure, Function, and Use in Biology and Medicine; Ogita, Z, Ed.; Willey-Liss, Inc: New York, NY, USA, 1990; pp. 819–841.
[58]
Farres, J; Moreno, A; Crosas, B; Cederlund, E. Human and rat Class IV alcohol dehydrogenases-Correlations of primary structure with enzymatic properties. Adv. Exp. Med. Biol？1995, 372, 331–339.
[59]
Mourad, N; Woronick, CL. Crystallization of human liver alcohol dehydrogenase. Arch. Biochem. Biophy？1967, 121, 431–439.
[60]
Mardh, G; Vallee, BL. Human Class I alcohol dehydrogenases catalyze the interconversion of alcohols and aldehyds in the metabolism of dopamine. Biochemistry？1986, 25, 7279–7282.
[61]
Mardh, G; Dingley, AL; Auld, DS; Vallee, BL. Human class II (π) alcohol dehydrogenase has a redox-specific function in norepinephrine metabolism. Proc. Natl. Acad. Sci. USA？1986, 83, 8908–8912.
[62]
Consalvi, V; Mardh, G; Vallee, BL. Human alcohol dehydrogenase and serotonin metabolism. Biochem. Biopys. Res. Commun？1986, 139, 109–1016.
[63]
Keung, W-M. Human liver alcohol dehydrogenases catalyze the oxidation of the intermediary alcohols of the shunt pathway of mevalonate metabolism. Biochem. Biophys. Res. Commun？1991, 174, 701–707.
[64]
MacEvily, AJ; Holmquist, B; Auld, DS; Vallee, BL. 3β-hydroxy-5β-steroid dehydrogenase activity of human liver alcohol dehydrogenase is specific to γ-subunits. Biochemistry？1988, 27, 4284–4288.
[65]
Mardh, G; Falchuck, KH; Auld, DS; Vallee, BL. Testosterone allosterically regulates ethanol oxidation by homo- and heterodimeric γ-subunits-containing isozymes of human alcohol dehydrogenase. Proc. Natl. Acad. Sci. USA？1986, 83, 2836–2840.
[66]
Biosynthesis of bile acids: Cell Functions and Metabolic Map I; Tokyo Kagaku Doujinn: Tokyo, Japan, 1997; pp. 102–105.
[67]
Molotkov, A; Fan, X; Deltour, L; Foglio, MH; Martras, S; Farres, J; Pares, X; Duester, G. Stimulation of retinoic acid production and growth by ubiquitously expressed alcohol dehydrogenase. Pro. Natl. Acad. Sci. USA？2002, 99, 5337–5342.
[68]
Jornvall, H. The alcohol dehydrogenase system. In Toward Molecular Basis of Alcohol Use and Abuse; Jansson, B, Jornvall, H, Rydberg, U, Terenius, L, Vallee, BL, Eds.; Birkhauser Verlag: Basel, Switzerland, 1994; pp. 221–229.
[69]
Koivusalo, M; Baumann, M; Uotila, L. Evidence for the identity of glutathione-dependent formaldehyde dehydrogenase and Class III alcohol dehydrogenase. FEBS Lett？1989, 257, 105–109.
[70]
Liu, L; Hausladen, A; Zeng, M; Que, L; Heitman, J; Stamler, JS. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature？2001, 40, 490–494.
[71]
Gotoh, Y; Sumimoto, H; Minakami, S. Formation of 20-oxoleukotrien B4 by an alcohol dehydrogenase isolated from human neutrophils. Biochim. Biophys. Acta？1990, 1043, 52–56.
[72]
Boleda, MD; Saubi, N; Farres, J; Pares, X. Physiological substrates for rat alcohol dehydrogenase classes: Aldehydes of lipid peroxidation, ω-hydroxyfatty acids, and retinoid. Arch. Biochem. Biophys？1993, 307, 85–90.
[73]
Han, CL; Liao, CS; Wu, CW; Hwong, CL; Lee, AR; Yin, SJ. Contribution to first-pass metabolism of ethanol for retinol oxidation in human alcohol dehydrogenase family. Implications for etiology of fetal alcohol syndrome and alcohol-related diseases. Eur. J. Biochem？1998, 254, 25–31.
[74]
Deltour, L; Ang, HL; Duester, G. Ethanol inhibition of retinoic acid synthesis as a potential mechanism for fetal alcohol syndrome. FASEB J？1996, 10, 1050–1057.
[75]
Canstro, C; Postlewait, JH; Gonzalez-Duarte, R; Albalat, R. Is retinoic acid genetic machinery a chordate innovation. Evol. Dev？2006, 8, 394–406.
